13-Feb-2026
Business Wire (Wed, 4-Feb 8:15 AM ET)
Hologic Announces Financial Results for First Quarter of Fiscal 2026
Business Wire (Thu, 29-Jan 4:02 PM ET)
Globe Newswire (Sat, 17-Jan 1:00 PM ET)
Business Wire (Thu, 15-Jan 7:00 PM ET)
Business Wire (Tue, 13-Jan 9:00 AM ET)
PRNewswire (Thu, 8-Jan 11:51 AM ET)
PRNewswire (Wed, 7-Jan 5:13 PM ET)
PRNewswire (Tue, 23-Dec 6:56 PM ET)
Business Wire (Tue, 16-Dec 8:08 AM ET)
PRNewswire (Thu, 11-Dec 8:54 PM ET)
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Hologic trades on the NASDAQ stock market under the symbol HOLX.
As of February 13, 2026, HOLX stock price climbed to $75.04 with 1,962,418 million shares trading.
HOLX has a beta of 0.06, meaning it tends to be less sensitive to market movements. HOLX has a correlation of 0.00 to the broad based SPY ETF.
HOLX has a market cap of $16.75 billion. This is considered a Large Cap stock.
Last quarter Hologic reported $1 billion in Revenue and $1.04 earnings per share. This fell short of revenue expectation by $-24 million and missed earnings estimates by -$.06.
In the last 3 years, HOLX traded as high as $87.88 and as low as $51.90.
The top ETF exchange traded funds that HOLX belongs to (by Net Assets): VTI, VOO, VB, VBR, IVV.
HOLX has outperformed the market in the last year with a price return of +18.0% while the SPY ETF gained +13.0%. However, in the short term, HOLX had mixed performance relative to the market. It has underperformed in the last 3 months, returning +1.1% vs +1.7% return in SPY. But in the last 2 weeks, HOLX shares have fared better than the market returning +0.1% compared to SPY -1.5%.
HOLX support price is $74.49 and resistance is $75.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HOLX shares will trade within this expected range on the day.